The Valley Desk

NCT00411645 · Interventional trial

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Overall registry status Completed

Phase 3

Conditions Cytomegalovirus Infections

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov